Results 61 to 70 of about 6,717 (218)

Diet-related urine collections: assistance in categorization of hyperoxaluria

, 2021
Hyperoxaluria, one of the major risk factors for calcium oxalate urolithiasis and nephrocalcinosis, causes significant morbidity and mortality and should therefore be detected and treated as soon as possible. An early, consequent and adequate evaluation,
Dill, Hannah, Hoppe, Bernd, Martin-Higueras, Cristina   +2 more
core   +1 more source

Kidney Stone, Nutritional Perceptions and Impact of Tea on Stone Formation

Phytochemicals in Food and Medicine, Volume 1, Issue 2, June 2026.
ABSTRACT The significant financial burden that urinary stone disease places on healthcare systems is only anticipated to increase over time. It is becoming more common over the globe. It is an increasing urinary condition that impacts around 12% of the global population, and environmental variables appear to be a key contributor.
Munir Ahmed, Danish Kamal, Umber Mubeen, Sakhawat Riaz, Amber Tehseen, Muhammad Mazahir   +5 more
wiley   +1 more source

Carrier screening in the reproductive setting—Are there medical implications for the heterozygote?—A guide for clinicians

Pregnancy, Volume 2, Issue 3, May 2026.
Abstract Carrier screening for genetic conditions performed preconception or during pregnancy allows identification of fetal risk for inherited autosomal recessive and X‐linked conditions. The goal is to identify at‐risk patients/couples and offer them reproductive options such as preimplantation genetic diagnosis, prenatal testing, or targeted newborn
Emily B. Rosenfeld, Nicole Kasatkin, Bi Liu Yu, Milen Velinov, Justin S. Brandt, Elena Ashkinadze   +5 more
wiley   +1 more source

ALLN-177, oral enzyme therapy for hyperoxaluria

, 2019
PURPOSE: To evaluate the potential of ALLN-177, an orally administered, oxalate-specific enzyme therapy to reduce urine oxalate (UOx) excretion in patients with secondary hyperoxaluria.
Lingeman, James E., Pareek, Gyan, Easter, Linda, Grujic, Danica, Brettman, Lee, Langman, Craig B., Pease, Rita   +6 more
core   +1 more source

Sodium thiosulfate ameliorates oxidative stress and preserves renal function in hyperoxaluric rats. [PDF]

PLoS ONE, 2015
BACKGROUND: Hyperoxaluria causes crystal deposition in the kidney, which leads to oxidative stress and to injury and damage of the renal epithelium. Sodium thiosulfate (STS, Na2S2O3) is an anti-oxidant, which has been used in human medicine for decades ...
Rakesh K Bijarnia, Matthias Bachtler, Prakash G Chandak, Harry van Goor, Andreas Pasch   +4 more
doaj   +1 more source

Paediatric renal transplantation: Paediatric surgeons' perspective

Surgical Practice, Volume 30, Issue 2, Page 117-122, May 2026.
Abstract Renal transplantation is the most effective treatment for paediatric end‐stage renal disease (ESRD), offering advantages in survival, growth and neurocognitive development that surpass other renal replacement therapies (RRT). The paediatric setting, however, introduces distinct complexities that distinguish it from adult practice.
Adrian Chi‐heng Fung, Mary Kim Elizabeth Tan Cudia, Ivy Hau‐yee Chan, Kenneth Kak‐yuen Wong   +3 more
wiley   +1 more source

Protective Effects of Quercetin on Oxidative Stress-Induced Tubular Epithelial Damage in the Experimental Rat Hyperoxaluria Model

Medicina, 2021
Background and Objectives: The most common kidney stones are calcium stones and calcium oxalate (CaOx) stones are the most common type of calcium stones. Hyperoxaluria is an essential risk factor for the formation of these stones.
Ahmet Guzel, Sedat Yunusoglu, Mustafa Calapoglu, Ibrahim Aydın Candan, Ibrahim Onaran, Meral Oncu, Osman Ergun, Taylan Oksay   +7 more
doaj   +1 more source

A Case Study and Review of the Literature on IgA Nephropathy in Crohn's Disease

Clinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT IgA nephropathy (IgAN) is the most frequently reported glomerular disease associated with inflammatory bowel disease (IBD), particularly Crohn's disease (CD), although pediatric cases remain rare. We report IgAN in a 16‐year‐old male with CD following intestinal surgery and during long‐term infliximab therapy, with renal impairment occurring ...
Giovanna Fernanda Vazzana, Alessia Romano, Chiara Casuscelli, Alberto La Spada, Domenico Santoro, Roberto Chimenz, Claudio Romano   +6 more
wiley   +1 more source

Hyperoxaluria: a gut–kidney axis?

, 2011
Hyperoxaluria leads to urinary calcium oxalate (CaOx) supersaturation, resulting in the formation and retention of CaOx crystals in renal tissue. CaOx crystals may contribute to the formation of diffuse renal calcifications (nephrocalcinosis) or stones ...
D'Haese, Patrick C., Stef Robijn, Vervaet, Benjamin, Hoppe, Bernd, Robijn, Stef, d' Haese, Patrick C., Anja Verhulst, Benjamin A. Vervaet, Patrick C. D'Haese, Bernd Hoppe, Verhulst, Anja, Vervaet, Benjamin A.   +11 more
core   +1 more source

Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1

, 2021
Background and objectives In the rare disease primary hyperoxaluria type 1, overproduction of oxalate by the liver causes kidney stones, nephrocalcinosis, kidney failure, and systemic oxalosis.
Jaap W. Groothoff, GROOTHOFF, Jaap W., HARAMBAT, Jerome, DESCHENES, Georges, HULTON, Sally-Anne, van’t Hoff, William G., David V. Erbe, LORCH, Ulrike, Akshay K. Vaishnaw, Ulrike Lorch, HASLETT, Patrick, GARG, Pushkal P., Pushkal P. Garg, William G. van’t Hoff, VAISHNAW, Akshay K., Dawn S. Milliner, Tracy L. McGregor, Pierre Cochat, MAGEN, Daniella, TALAMUDUPULA, Sandeep, Patrick Haslett, LIESKE, John C., Yaacov Frishberg, Sally-Anne Hulton, MCGREGOR, Tracy L., Jérôme Harambat, Bahru A. Habtemariam, COCHAT, Pierre, MILLINER, Dawn S., LU, Jiandong, Georges Deschênes, ERBE, David V., HABTEMARIAM, Bahru A., STUDY, Collaborators, Jiandong Lu, Daniella Magen, John C. Lieske, VAN'T HOFF, William G., Sandeep Talamudupula, FRISHBERG, Yaacov   +39 more
core   +1 more source